KORU MEDICAL SYSTEMS INC (KRMD) Stock Fundamental Analysis

NASDAQ:KRMD • US7599101026

4.67 USD
+0.3 (+6.86%)
At close: Feb 13, 2026
4.67 USD
0 (0%)
After Hours: 2/13/2026, 8:21:05 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

3

Overall KRMD gets a fundamental rating of 3 out of 10. We evaluated KRMD against 185 industry peers in the Health Care Equipment & Supplies industry. While KRMD seems to be doing ok healthwise, there are quite some concerns on its profitability. While showing a medium growth rate, KRMD is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • In the past year KRMD has reported negative net income.
  • In the past year KRMD had a positive cash flow from operations.
  • In the past 5 years KRMD always reported negative net income.
  • In the past 5 years KRMD always reported negative operating cash flow.
KRMD Yearly Net Income VS EBIT VS OCF VS FCFKRMD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M

1.2 Ratios

  • KRMD has a Return On Assets (-13.70%) which is comparable to the rest of the industry.
  • Looking at the Return On Equity, with a value of -22.55%, KRMD is in the better half of the industry, outperforming 60.22% of the companies in the same industry.
Industry RankSector Rank
ROA -13.7%
ROE -22.55%
ROIC N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
KRMD Yearly ROA, ROE, ROICKRMD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60

1.3 Margins

  • With a decent Gross Margin value of 62.32%, KRMD is doing good in the industry, outperforming 65.05% of the companies in the same industry.
  • In the last couple of years the Gross Margin of KRMD has remained more or less at the same level.
  • The Profit Margin and Operating Margin are not available for KRMD so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
KRMD Yearly Profit, Operating, Gross MarginsKRMD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. Health

2.1 Basic Checks

  • KRMD does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • KRMD has more shares outstanding than it did 1 year ago.
  • KRMD has more shares outstanding than it did 5 years ago.
  • KRMD has a better debt/assets ratio than last year.
KRMD Yearly Shares OutstandingKRMD Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
KRMD Yearly Total Debt VS Total AssetsKRMD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • KRMD has an Altman-Z score of 12.04. This indicates that KRMD is financially healthy and has little risk of bankruptcy at the moment.
  • KRMD has a Altman-Z score of 12.04. This is amongst the best in the industry. KRMD outperforms 92.47% of its industry peers.
  • A Debt/Equity ratio of 0.03 indicates that KRMD is not too dependend on debt financing.
  • KRMD has a better Debt to Equity ratio (0.03) than 69.89% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 12.04
ROIC/WACCN/A
WACC9.71%
KRMD Yearly LT Debt VS Equity VS FCFKRMD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 2.48 indicates that KRMD has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.48, KRMD is in line with its industry, outperforming 52.15% of the companies in the same industry.
  • A Quick Ratio of 1.92 indicates that KRMD should not have too much problems paying its short term obligations.
  • KRMD has a Quick ratio (1.92) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.48
Quick Ratio 1.92
KRMD Yearly Current Assets VS Current LiabilitesKRMD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • KRMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 30.00%, which is quite impressive.
  • Looking at the last year, KRMD shows a very strong growth in Revenue. The Revenue has grown by 22.12%.
  • The Revenue has been growing slightly by 7.76% on average over the past years.
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
Revenue 1Y (TTM)22.12%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%27.18%

3.2 Future

  • The Earnings Per Share is expected to grow by 38.31% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, KRMD will show a quite strong growth in Revenue. The Revenue will grow by 18.99% on average per year.
EPS Next Y66.85%
EPS Next 2Y46.73%
EPS Next 3Y38.31%
EPS Next 5YN/A
Revenue Next Year22.02%
Revenue Next 2Y19.94%
Revenue Next 3Y18.99%
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
KRMD Yearly Revenue VS EstimatesKRMD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M 50M
KRMD Yearly EPS VS EstimatesKRMD Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.05 -0.05 -0.1 -0.15 -0.2

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for KRMD. In the last year negative earnings were reported.
  • The Price/Forward Earnings ratio is 305.23, which means the current valuation is very expensive for KRMD.
  • KRMD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. KRMD is cheaper than 63.98% of the companies in the same industry.
  • The average S&P500 Price/Forward Earnings ratio is at 28.06. KRMD is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 305.23
KRMD Price Earnings VS Forward Price EarningsKRMD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
KRMD Per share dataKRMD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6 0.8

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates KRMD does not grow enough to justify the current Price/Earnings ratio.
  • KRMD's earnings are expected to grow with 38.31% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y46.73%
EPS Next 3Y38.31%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. Dividend

5.1 Amount

  • No dividends for KRMD!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

KORU MEDICAL SYSTEMS INC

NASDAQ:KRMD (2/13/2026, 8:21:05 PM)

After market: 4.67 0 (0%)

4.67

+0.3 (+6.86%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)03-04
Inst Owners57.04%
Inst Owner ChangeN/A
Ins Owners8.38%
Ins Owner Change6.5%
Market Cap216.31M
Revenue(TTM)39.07M
Net Income(TTM)-3.71M
Analysts80
Price Target6.73 (44.11%)
Short Float %1.6%
Short Ratio3.68
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)64.99%
Min EPS beat(2)29.97%
Max EPS beat(2)100%
EPS beat(4)4
Avg EPS beat(4)39.61%
Min EPS beat(4)3.88%
Max EPS beat(4)100%
EPS beat(8)8
Avg EPS beat(8)38.65%
EPS beat(12)12
Avg EPS beat(12)33.06%
EPS beat(16)15
Avg EPS beat(16)30.05%
Revenue beat(2)2
Avg Revenue beat(2)5.58%
Min Revenue beat(2)5.51%
Max Revenue beat(2)5.66%
Revenue beat(4)3
Avg Revenue beat(4)3.78%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)6.5%
Revenue beat(8)7
Avg Revenue beat(8)4.72%
Revenue beat(12)7
Avg Revenue beat(12)1.12%
Revenue beat(16)11
Avg Revenue beat(16)2.1%
PT rev (1m)12.82%
PT rev (3m)17.86%
EPS NQ rev (1m)9.17%
EPS NQ rev (3m)9.17%
EPS NY rev (1m)13.33%
EPS NY rev (3m)59.38%
Revenue NQ rev (1m)1.31%
Revenue NQ rev (3m)3.58%
Revenue NY rev (1m)1.04%
Revenue NY rev (3m)2.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 305.23
P/S 5.54
P/FCF N/A
P/OCF 704.15
P/B 13.14
P/tB 13.71
EV/EBITDA N/A
EPS(TTM)-0.07
EYN/A
EPS(NY)0.02
Fwd EY0.33%
FCF(TTM)0
FCFYN/A
OCF(TTM)0.01
OCFY0.14%
SpS0.84
BVpS0.36
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -13.7%
ROE -22.55%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.32%
FCFM N/A
ROA(3y)-30.34%
ROA(5y)-21.02%
ROE(3y)-43.74%
ROE(5y)-29.41%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.65%
GM growth 5Y-0.23%
F-Score5
Asset Turnover1.44
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 57.64%
Cap/Sales 1.24%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.48
Quick Ratio 1.92
Altman-Z 12.04
F-Score5
WACC9.71%
ROIC/WACCN/A
Cap/Depr(3y)239.72%
Cap/Depr(5y)210.83%
Cap/Sales(3y)5.63%
Cap/Sales(5y)4.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%33.33%
EPS Next Y66.85%
EPS Next 2Y46.73%
EPS Next 3Y38.31%
EPS Next 5YN/A
Revenue 1Y (TTM)22.12%
Revenue growth 3Y12.72%
Revenue growth 5Y7.76%
Sales Q2Q%27.18%
Revenue Next Year22.02%
Revenue Next 2Y19.94%
Revenue Next 3Y18.99%
Revenue Next 5YN/A
EBIT growth 1Y43.09%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year104.2%
EBIT Next 3Y44.01%
EBIT Next 5YN/A
FCF growth 1Y96.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y106.61%
OCF growth 3YN/A
OCF growth 5YN/A

KORU MEDICAL SYSTEMS INC / KRMD FAQ

What is the fundamental rating for KRMD stock?

ChartMill assigns a fundamental rating of 3 / 10 to KRMD.


What is the valuation status for KRMD stock?

ChartMill assigns a valuation rating of 1 / 10 to KORU MEDICAL SYSTEMS INC (KRMD). This can be considered as Overvalued.


Can you provide the profitability details for KORU MEDICAL SYSTEMS INC?

KORU MEDICAL SYSTEMS INC (KRMD) has a profitability rating of 2 / 10.


Can you provide the financial health for KRMD stock?

The financial health rating of KORU MEDICAL SYSTEMS INC (KRMD) is 5 / 10.


Can you provide the expected EPS growth for KRMD stock?

The Earnings per Share (EPS) of KORU MEDICAL SYSTEMS INC (KRMD) is expected to grow by 66.85% in the next year.